^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SG2501

    i
    Other names: SG2501, SG 2501, SG-2501
    Associations

    News

    Trials
    Company:
    Sumgen Biotech
    Drug class:
    CD38 inhibitor, CD47 inhibitor
    Related drugs:
    Associations

    News

    Trials
    9ms
    SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. (clinicaltrials.gov)
    P1, N=72, Recruiting, Hangzhou Sumgen Biotech Co., Ltd. | Phase classification: P1a/1b --> P1
    Phase classification
    |
    SG2501
    almost2years
    SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. (clinicaltrials.gov)
    P1a/1b, N=72, Recruiting, Hangzhou Sumgen Biotech Co., Ltd. | Trial completion date: Sep 2024 --> Apr 2025 | Trial primary completion date: Feb 2023 --> Dec 2024
    Trial completion date • Trial primary completion date
    |
    CD8 (cluster of differentiation 8) • IL6 (Interleukin 6) • CD38 (CD38 Molecule) • IL2 (Interleukin 2) • NCAM1 (Neural cell adhesion molecule 1)
    |
    CD38 expression
    |
    SG2501
    over2years
    SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. (clinicaltrials.gov)
    P1a/1b, N=72, Recruiting, Hangzhou Sumgen Biotech Co., Ltd. | Not yet recruiting --> Recruiting | Initiation date: Apr 2022 --> Aug 2022
    Enrollment open • Trial initiation date
    |
    CD8 (cluster of differentiation 8) • IL6 (Interleukin 6) • CD38 (CD38 Molecule) • IL2 (Interleukin 2) • NCAM1 (Neural cell adhesion molecule 1)
    |
    CD38 expression
    |
    SG2501
    over2years
    SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. (clinicaltrials.gov)
    P1a/1b, N=72, Not yet recruiting, Hangzhou Sumgen Biotech Co., Ltd.
    New P1 trial
    |
    CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • IL6 (Interleukin 6) • CD38 (CD38 Molecule) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • NCAM1 (Neural cell adhesion molecule 1) • IL1B (Interleukin 1, beta)
    |
    CD38 expression
    |
    SG2501